0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Neurology | 
Editorial |  ONLINE FIRST
Olaf Stüve, MD, PhD; Diego Centonze, MD, PhD
JAMA Neurol. Published online February 09, 2015. doi:10.1001/jamaneurol.2014.4494

JAMA Neurology | 
Original Investigation |  ONLINE FIRST
Anna He, MBBS; Tim Spelman, MBBS, MSc; Vilija Jokubaitis, PhD; et al.
JAMA Neurol. Published online February 09, 2015. doi:10.1001/jamaneurol.2014.4147
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation | 
Keita Takahashi, MD; Yuji Kurihara, PhD; Yume Suzuki, MD, PhD; et al.
JAMA Neurol. 2015;72(2):176-179. doi:10.1001/jamaneurol.2014.3613.
Includes: Supplemental Content

JAMA Neurology | 
Editorial | 
Jaime Imitola, MD; Michael K. Racke, MD
JAMA Neurol. 2015;72(2):145-147. doi:10.1001/jamaneurol.2014.3860.

JAMA Neurology | 
Original Investigation | 
Dalia L. Rotstein, MD; Brian C. Healy, PhD; Muhammad T. Malik, MD; et al.
JAMA Neurol. 2015;72(2):152-158. doi:10.1001/jamaneurol.2014.3537.
Includes: CME

JAMA Neurology | 
Editorial | 
M. Mateo Paz Soldán, MD, PhD; Brian G. Weinshenker, MD
JAMA Neurol. 2015;72(2):147-149. doi:10.1001/jamaneurol.2014.3831.

JAMA Neurology | 
Original Investigation | 
Richard A. Nash, MD; George J. Hutton, MD; Michael K. Racke, MD; et al.
JAMA Neurol. 2015;72(2):159-169. doi:10.1001/jamaneurol.2014.3780.
Includes: CME, Supplemental Content

JAMA | 
Editorial | 
Stephen L. Hauser, MD
JAMA. 2015;313(3):251-252. doi:10.1001/jama.2014.18150.

JAMA | 
Preliminary Communication | 
Richard K. Burt, MD; Roumen Balabanov, MD; Xiaoqiang Han, MD; et al.
JAMA. 2015;313(3):275-284. doi:10.1001/jama.2014.17986.
Includes: Supplemental Content

JAMA | 
Original Investigation | 
Nikolai Madrid Scheller, MB; Henrik Svanström, MSc; Björn Pasternak, MD, PhD; et al.
JAMA. 2015;313(1):54-61. doi:10.1001/jama.2014.16946.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Editorial  | 
Treatment Decisions for Patients With Active Multiple Sclerosis
Olaf Stüve, MD, PhD; Diego Centonze, MD, PhD
JAMA Neurology
Original Investigation  | 
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis
Anna He, MBBS; Tim Spelman, MBBS, MSc; Vilija Jokubaitis, PhD; et al.
JAMA Neurology
Original Investigation  | 
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis
Keita Takahashi, MD; Yuji Kurihara, PhD; Yume Suzuki, MD, PhD; et al.
JAMA Neurology
Editorial  | 
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Jaime Imitola, MD; Michael K. Racke, MD